Quick Overview: Panelists Richard S. Finn, MD; Richard H. Marshall, MD; Amit Singal, MD, MSCS; and Arndt Vogel, MD, PhD, highlight key factors ... Arndt Vogel, MD, outlines the benefits and risks of After reviewing the historic management of hepatocellular carcinoma, experts reflect on the nuances of
Transitioning To Systemic Therapy In - Detailed Overview & Context
Panelists Richard S. Finn, MD; Richard H. Marshall, MD; Amit Singal, MD, MSCS; and Arndt Vogel, MD, PhD, highlight key factors ... Arndt Vogel, MD, outlines the benefits and risks of After reviewing the historic management of hepatocellular carcinoma, experts reflect on the nuances of Richard Finn, MD, and Jeff Geschwind, MD, discuss how to decide when it is appropriate for patients to be placed on This is the sixth episode of our ongoing "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist ... Dr Mark Kris continues a discussion about considerations related to the many faces of progression on
Panelists Ghassan K. Abou-Alfa, MD; Amit G. Singal, MD; and Richard Finn, MD, outline patient and disease factors to consider ... In this video, Dr. Diane Gehart reviews the foundational Thomas Flaig, MD, University of Colorado Anschutz Medical Campus, Aurora, CO, provides an overview of the management of ... A discussion on when a dermatologist should make a referral for surgery, radiotherapy, or to a medical oncologist, and when to ... AIM at Melanoma Symposium September 12, 2019 Kelly Olino, MD, FACS. In this session, Dr Jason Chandler discusses strategies for
Bradley J. Monk, MD, et al; discuss their choice of go-to backbone chemotherapy for newly diagnosed advanced epithelial ovarian ... In this video series, Dr. Daniel Roberson of Mayo Clinic, Dr. Abhinav Khanna of Mayo Clinic, and Dr. Nitin Yerram of Hackensack ...
